Related Experiment Videos
Can we better prioritize resources for cost-utility research?
Peter J Neumann1, Allison B Rosen, Dan Greenberg
1Harvard School of Public Health, Boston, MA 02115, USA. pneumann@hsph.harvard.edu.
Summary
Cost-utility analyses (CUAs) often focus on pharmaceuticals and surgery, but underrepresent key health issues like mental health and substance abuse. Research funding should better align with disease burden and public health priorities.
Area of Science:
- Health Economics
- Health Services Research
- Public Health Policy
Background:
- Cost-utility analyses (CUAs) are crucial for evaluating healthcare interventions.
- Understanding the scope of published CUAs is essential for assessing research priorities.
Purpose of the Study:
- To analyze 512 CUAs published between 1976-2001.
- To determine intervention types, disease burden alignment, and coverage of Healthy People 2010 priorities.
Main Methods:
- Comparative analysis of CUA disease coverage against U.S. disease burden rankings.
- Assessment of CUA alignment with Healthy People 2010 health priorities.
Main Results:
- CUAs predominantly studied pharmaceuticals (40%) and surgical procedures (16%).
- Overrepresentation in cerebrovascular disease, diabetes, breast cancer, and HIV/AIDS.
- Underrepresentation in depression, bipolar disorder, injuries, and substance abuse; limited focus on Healthy People 2010 areas like physical activity.
Conclusions:
- Published CUAs partially reflect disease burden but neglect significant health concerns.
- Need for strategic resource allocation in CUA research to maximize societal benefit.